The treatment of patients in a modern dental practice involves therapies, which enhance predictability and reduce risk. Over the past decade, clinical research has resulted in novel treatments such as biologics, but also a better characterization of patients with inherit risk. When the dental practitioner combines this knowledge, an improvement in patient outcomes occurs. This course will review risk profiles and treatment of peri-implant disease, use of adjacent for bone regeneration, periodontal non-surgical therapies and dental technologies in the pipeline.
- Acquire the basic knowledge regarding innovation in periodontics and implant dentistry
- Be exposed to advanced procedures and state-of-the-art techniques.
- Be able to identify indications for new technologies in clinical practice
- Be exposed to future developments in periodontics and implantology
Dr. Joseph Fiorellini is Professor in Department of Periodontics at the University of Pennsylvania School of Dental Medicine. In 1990, he received his DMD from the Harvard School of Dental Medicine and in 1993 was awarded the DMSc degree in the field of Oral Biology and a Certificate in Periodontology. Dr. Fiorellini has published over 100 manuscripts, reviews or textbook chapters and received awards related to research including NIH and IADR research travel grants, The AAP Young Investigators Award, The Academy of Osseointegration Research Award, and The European Association for Osseointegration Research Prize. Currently, he is a the Chair of the American Dental Association Commission for Continuing Education Recognition Program and Board Director of the Academy of Osseointegration In addition, he serves as the Associate Editor of the International Journal of Oral and Maxillofacial Implants and is a member of several editorial boards including of the International Journal of Periodontics and Restorative Dentistry and the Journal of Periodontology.